Aristo Bio-Tech and Lifescience Ltd

NSE: ARISTO · Chemicals & Petrochemicals · 8 announcements

Share price: ₹94.00
Market cap: ₹63.99 Cr
Revenue (annual): ₹363.7 Cr
Net profit (annual): ₹7.18 Cr
P/E (TTM): 8.9×Sector 37.2×
Promoter holding: 73.42%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 2 Board Meeting Outcome 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 May 2026 15:23 IST NSE

Financial Results

Aristo Bio-Tech and Lifescience H2 FY26 Results: Turns Profitable, Net Profit ₹3 Cr

Aristo Bio-Tech and Lifescience Ltd reported revenue from operations of ₹107.3 Cr (+3.3% YoY) and net profit of ₹3 Cr for H2 FY26.

Key figure: Net profit ₹3 Cr

Open full results → Read the filing ↗

30 May 2026 15:21 IST NSE

Financial Results

Aristo Bio-Tech and Lifescience Financial Results

Aristo Bio-Tech approved audited FY26 financial results and recommended a final dividend of ₹0.60 per share. The results showed strong annual performance with unmodified audit opinions.

Read the filing ↗